ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,862 | -2.9% | 5,950 | +52.2% | 0.00% | – |
| Q2 2023 | $19,433 | +16.2% | 3,910 | +15.5% | 0.00% | – |
| Q1 2023 | $16,722 | +368.0% | 3,385 | +496.0% | 0.00% | – |
| Q4 2022 | $3,573 | -87.2% | 568 | -77.9% | 0.00% | -100.0% |
| Q3 2022 | $28,000 | -3.4% | 2,569 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $29,000 | +262.5% | 2,569 | +198.7% | 0.00% | – |
| Q1 2022 | $8,000 | – | 860 | +2865.5% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 29 | -71.0% | 0.00% | – |
| Q3 2021 | $3,000 | +200.0% | 100 | +233.3% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 30 | +11.1% | 0.00% | – |
| Q1 2021 | $1,000 | -50.0% | 27 | -35.7% | 0.00% | – |
| Q3 2020 | $2,000 | -33.3% | 42 | -68.2% | 0.00% | – |
| Q1 2020 | $3,000 | – | 132 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $26,829,000 | 10.04% |
| Wildcat Capital Management, LLC | 1,716,370 | $25,608,000 | 4.17% |
| TPG GP A, LLC | 18,716,306 | $279,247,000 | 2.79% |
| Casdin Capital, LLC | 2,650,000 | $39,538,000 | 1.11% |
| Lombard Odier Asset Management (Switzerland) SA | 996,116 | $14,862,000 | 0.95% |
| Coastal Bridge Advisors, LLC | 301,929 | $4,505,000 | 0.94% |
| HARBOR CAPITAL ADVISORS, INC. | 119,547 | $1,784,000 | 0.65% |
| Pier Capital, LLC | 294,968 | $4,401,000 | 0.46% |
| Navalign, LLC | 64,428 | $961,000 | 0.38% |
| Gratus Capital, LLC | 191,871 | $2,863,000 | 0.26% |